Maitreya Medicare (NSE:MAITREYA) EBITDA Margin %: 18.41% (As of Sep. 2023)


NSE:MAITREYA Maitreya Medicare Ltd NSE:MAITREYA
18 GF Score
Price ₹137.85
View Full Analysis

What is Maitreya Medicare EBITDA Margin %?

Maitreya Medicare NSE:MAITREYA -0.11% 18 EBITDA Margin % is 18.41% as of Sep. 2023. GuruFocus rates NSE:MAITREYA with a GF Score™ of 18/100.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Maitreya Medicare's EBITDA for the six months ended in Sep. 2023 was ₹45.7 Mil. Maitreya Medicare's Revenue for the six months ended in Sep. 2023 was ₹247.9 Mil. Therefore, Maitreya Medicare's EBITDA margin for the quarter that ended in Sep. 2023 was 18.41%.

Maitreya Medicare  (NSE:MAITREYA) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Maitreya Medicare EBITDA Margin % Related Terms

Maitreya Medicare EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Maitreya Medicare's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maitreya Medicare EBITDA Margin % Chart

Maitreya Medicare Annual Data
Trend Mar21 Mar22 Mar23
EBITDA Margin %
13.23 7.13 19.71

Maitreya Medicare Semi-Annual Data
Mar21 Mar22 Mar23 Sep23
EBITDA Margin % 0.00 0.00 0.00 18.41

NSE:MAITREYA vs HCA, DVA, THC: EBITDA Margin % Comparison

For the Medical Care Facilities subindustry, Maitreya Medicare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Maitreya Medicare EBITDA Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Maitreya Medicare's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Maitreya Medicare's EBITDA Margin % falls into.


NSE:MAITREYA
18GF Score
Maitreya Medicare Ltd NSE:MAITREYA
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maitreya Medicare EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Maitreya Medicare's EBITDA Margin % for the fiscal year that ended in Mar. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=77.632/393.8
=19.71 %

Maitreya Medicare's EBITDA Margin % for the quarter that ended in Sep. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=45.651/247.936
=18.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 18.41% mean?
Maitreya Medicare (NSE:MAITREYA) has a EBITDA Margin % of 18.41% as of Sep. 2023. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Maitreya Medicare and its competitors.
Is Maitreya Medicare's EBITDA Margin % too high?
Maitreya Medicare's current EBITDA Margin % is 18.41%. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Maitreya Medicare's value of 18.41% is 79.8% above this industry median. Overall, Maitreya Medicare has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Maitreya Medicare's EBITDA Margin % compare to HCA and DVA?
Maitreya Medicare's EBITDA Margin % of 18.41% can be compared against companies in the Healthcare Providers & Services industry. The industry median EBITDA Margin % is 10.24. Maitreya Medicare's value of 18.41% is 79.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maitreya Medicare's current EBITDA Margin % of 18.41% is 79.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Maitreya Medicare and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maitreya Medicare's current EBITDA Margin % is 18.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maitreya Medicare stock overvalued right now?
Maitreya Medicare (NSE:MAITREYA) has a current EBITDA Margin % of 18.41%. The current EBITDA Margin % is 18.41% and 79.8% above the Healthcare Providers & Services industry median of 10.24. Maitreya Medicare's overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Maitreya Medicare (NSE:MAITREYA), the current EBITDA Margin % is 18.41% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Maitreya Medicare Business Description

Address Nr. Someshwara Char Rasta, Udhana - Magdalla Road, Surat, GJ, IND, 395007
Maitreya Medicare Ltd is Multi Superspeciality hospital. It is a 125 bedded hospital that provides multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care, and also offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine etc.
18GF Score

Get the complete analysis for NSE:MAITREYA

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹137.85
Price